Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
about
Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell linesPromoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epitheliaEpstein-Barr virus-specific methylation of human genes in gastric cancer cells.The role of oncogenes in gastrointestinal cancer.Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylationEpstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancerTSGene: a web resource for tumor suppressor genes.Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileEpstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri.Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.Late, isolated metastasis from poorly differentiated gastric cancer to the uterine cervixEpstein-Barr virus: more than 50 years old and still providing surprises.Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour.The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinomaReduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma.Epstein-Barr virus and nasopharyngeal carcinoma
P2860
Q28201307-5F7FC91A-13AF-4540-A104-6BFF3C3BA8F8Q28216984-84668639-5164-4F8F-B05F-A3B5E7E2E9EDQ34504229-442BF797-51C1-4083-A252-53BE49FA41F7Q34616409-DAE94C31-7524-497F-91A5-EDA7BBDC5847Q35586343-6EE004DB-84E2-492F-A1B6-0B4A46DE11E5Q35788760-7A6B6D91-7146-4B2E-AB8B-C48387239D94Q36397218-139296A6-5E53-40E1-8CD1-62C9C8A1E4B2Q36491150-880A1D7D-0F17-4143-B799-0558FDF20562Q36503818-7B50F787-AF2D-415D-9593-89812BA56B2FQ36687528-259C4E3D-6521-4532-84B1-B021A56FF843Q37433734-E196587A-1380-44A5-B3B8-EF6013F6A394Q37449248-7CAFAC7B-34C2-42CA-B959-C53B57DA2B6EQ37681227-C3D01EDE-0850-4D44-8085-7532B9C148BFQ38968588-C107802F-288C-45F9-9E78-ABF690055FB2Q40446210-E261FC44-9E78-4432-9287-D537D8DC27FCQ41921755-2BE52D7E-7EA8-47C9-BF7A-3B1CB9AA608AQ41983423-85C8CC3D-3599-4F19-99C7-23AA067BF8A0Q45729967-DA1A7300-D397-49F3-87C3-7A3C1590288CQ56947843-3A32109D-1D19-4A67-840C-513371EA1B73
P2860
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@en
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@nl
type
label
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@en
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@nl
prefLabel
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@en
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@nl
P2093
P1433
P1476
Loss of p16/CDKN2A tumor suppr ...... on in the body of the stomach.
@en
P2093
P356
10.1016/S0046-8177(00)80197-5
P407
P577
2000-01-01T00:00:00Z